Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Study of Chemoimmunotherapy for High-Risk Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma
- Status
- TERMINATED
- Phase
- NA
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Letrozole in Recurrent Gliomas
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- Status
- RECRUITING
- Phase
- PHASE2
Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic
- Status
- UNKNOWN
- Phase
- PHASE2
Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade Gliomas
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs
- Status
- TERMINATED
- Phase
- PHASE1